(Q85356388)
Statements
PARK2 and PACRG are commonly downregulated in clear-cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcome (English)
Marieta I Toma
Daniela Wuttig
Alexander Herr
Thomas Weber
Stefan Zastrow
Rainer Koch
Matthias Meinhardt
Gustavo B Baretton
Manfred P Wirth
Susanne Fuessel
2 November 2012